PortfoliosLab logoPortfoliosLab logo
FN vs. ALAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FN vs. ALAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fabrinet (FN) and Astera Labs, Inc. (ALAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FN achieves a 26.02% return, which is significantly lower than ALAB's 150.70% return.


FN

1D
-1.82%
1M
-18.48%
YTD
26.02%
6M
20.67%
1Y
115.55%
3Y*
64.45%
5Y*
44.47%
10Y*
31.23%

ALAB

1D
11.31%
1M
40.03%
YTD
150.70%
6M
153.69%
1Y
348.10%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FN vs. ALAB - Yearly Performance Comparison


2026 (YTD)20252024
FN
Fabrinet
26.02%107.06%14.09%
ALAB
Astera Labs, Inc.
150.70%25.60%152.00%

Correlation

The correlation between FN and ALAB is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (All Time)
Calculated using the full available price history since Mar 20, 2024

0.43

Fundamentals

Market Cap

FN:

$20.78B

ALAB:

$75.56B

EPS

FN:

$11.65

ALAB:

$1.48

PE Ratio

FN:

49.26

ALAB:

280.93

PS Ratio

FN:

4.90

ALAB:

75.08

PB Ratio

FN:

9.02

ALAB:

50.57

Total Revenue (TTM)

FN:

$4.24B

ALAB:

$1.00B

Gross Profit (TTM)

FN:

$509.75M

ALAB:

$760.99M

EBITDA (TTM)

FN:

$422.55M

ALAB:

$253.12M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FN vs. ALAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FN
FN Risk / Return Rank: 8686
Overall Rank
FN Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
FN Sortino Ratio Rank: 7979
Sortino Ratio Rank
FN Omega Ratio Rank: 7979
Omega Ratio Rank
FN Calmar Ratio Rank: 9292
Calmar Ratio Rank
FN Martin Ratio Rank: 9191
Martin Ratio Rank

ALAB
ALAB Risk / Return Rank: 9292
Overall Rank
ALAB Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
ALAB Sortino Ratio Rank: 9191
Sortino Ratio Rank
ALAB Omega Ratio Rank: 9090
Omega Ratio Rank
ALAB Calmar Ratio Rank: 9393
Calmar Ratio Rank
ALAB Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FN vs. ALAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fabrinet (FN) and Astera Labs, Inc. (ALAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FNALABDifference
Sharpe ratioReturn per unit of total volatility

-1.59

Sortino ratioReturn per unit of downside risk

-1.01

Omega ratioGain probability vs. loss probability

1.29

1.41

-0.12

Calmar ratioReturn relative to maximum drawdown

5.04

5.34

-0.30

Martin ratioReturn relative to average drawdown

12.51

10.53

+1.98

FN vs. ALAB - Sharpe Ratio Comparison

The current FN Sharpe Ratio is 1.74, which is lower than the ALAB Sharpe Ratio of 3.33. The chart below compares the historical Sharpe Ratios of FN and ALAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FN vs. ALAB - Drawdown Comparison

The maximum FN drawdown since its inception was -70.46%, which is greater than ALAB's maximum drawdown of -63.69%. Use the drawdown chart below to compare losses from any high point for FN and ALAB.


Loading charts...

Drawdown Indicators


FNALABDifference

Max Drawdown

Largest peak-to-trough decline

-70.46%

-63.69%

-6.77%

Max Drawdown (1Y)

Largest decline over 1 year

-23.14%

-60.19%

+37.05%

Max Drawdown (3Y)

Largest decline over 3 years

-37.47%

Max Drawdown (5Y)

Largest decline over 5 years

-38.70%

Max Drawdown (10Y)

Largest decline over 10 years

-51.11%

Current Drawdown

Current decline from peak

-23.14%

0.00%

-23.14%

Average Drawdown

Average peak-to-trough decline

-22.58%

-29.29%

+6.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.31%

30.50%

-21.19%

Volatility

FN vs. ALAB - Volatility Comparison

The current volatility for Fabrinet (FN) is 24.51%, while Astera Labs, Inc. (ALAB) has a volatility of 31.61%. This indicates that FN experiences smaller price fluctuations and is considered to be less risky than ALAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FNALABDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.51%

31.61%

-7.10%

Volatility (6M)

Calculated over the trailing 6-month period

55.49%

69.77%

-14.28%

Volatility (1Y)

Calculated over the trailing 1-year period

67.10%

96.74%

-29.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.82%

93.67%

-39.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.37%

93.67%

-45.30%

Dividends

FN vs. ALAB - Dividend Comparison

Neither FN nor ALAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FN vs. ALAB - Financials Comparison

This section allows you to compare key financial metrics between Fabrinet and Astera Labs, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20222023202420252026
1.21B
308.36M
(FN) Total Revenue
(ALAB) Total Revenue
Values in USD except per share items

FN vs. ALAB - Profitability Comparison

The chart below illustrates the profitability comparison between Fabrinet and Astera Labs, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
11.9%
76.3%
Portfolio components
FN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fabrinet reported a gross profit of 144.34M and revenue of 1.21B. Therefore, the gross margin over that period was 11.9%.

ALAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Astera Labs, Inc. reported a gross profit of 235.14M and revenue of 308.36M. Therefore, the gross margin over that period was 76.3%.

FN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fabrinet reported an operating income of 120.04M and revenue of 1.21B, resulting in an operating margin of 9.9%.

ALAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Astera Labs, Inc. reported an operating income of 61.83M and revenue of 308.36M, resulting in an operating margin of 20.1%.

FN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fabrinet reported a net income of 128.18M and revenue of 1.21B, resulting in a net margin of 10.6%.

ALAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Astera Labs, Inc. reported a net income of 80.31M and revenue of 308.36M, resulting in a net margin of 26.0%.


Frequently Asked Questions


FN and ALAB have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ALAB has higher volatility (31.61%) compared to FN (24.51%). In terms of maximum drawdown, FN dropped -70.46% vs ALAB's -63.69%.

ALAB currently has the higher Sharpe Ratio (3.33 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FN and ALAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer